The US Food and Drug Administration (FDA) late Wednesday approved the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the ...

The Food and Drug Administration has accepted Lannett’s abbreviated new drug application for fluticasone propionate and salmeterol inhalation powder in three strengths — a generic of GlaxoSmithKline's ...

PHILADELPHIA, June 1, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the U.S. Food and Drug Administration (FDA) has accepted the Abbreviated New Drug Application (ANDA) for ...

The US Food and Drug Administration (FDA) announced Thursday that it has denied Mylan’s petition that sought to block certain generic applications for Advair (fluticasone propionate and salmeterol).

LONDON (Reuters) - The prospect of generic copies of GlaxoSmithKline's best-selling lung drug Advair finally making it to market in the United States hit confidence in the drugmaker on Tuesday, ...

LONDON, March 29 (Reuters) - GlaxoSmithKline shares gained on Wednesday as lack of news about U.S. approval of a generic copy of its blockbuster inhaled lung drug Advair buoyed speculation that a ...

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and previous ...

Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg, 115mcg/21mcg, 230mcg/21mcg; per inh; metered-dose inhaler; CFC-free. Store at room temperature between 68° F and 77° F (20° C and 25° C) ...

Chippenham, UK - 22nd September 2020: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading inhalation CDMO, confirms the announcement made today by its partner Hikma Pharmaceuticals PLC, ...

LONDON, Sept 10 (Reuters) - The prospect of generic copiesof GlaxoSmithKline's best-selling lung drug Advairfinally making it to market in the United States hit confidencein the drugmaker on Tuesday, ...